Key Events Drive Significant Portion of Association Between Depression, Healthcare Utilization and Cost

July 17, 2020

Patients with major depressive disorder have higher healthcare utilization rates when they experience certain key clinical events, according to a new study.

Boosting Molecular Testing in Patients with GIST Would Have Minimal Cost Impact, Study Finds

July 06, 2020

Researchers cost-impact model calculates the cost to be 15 centers PMPY.

Patients with HCC Shoulder Economic Burdens, Have Insufficient Therapeutic Options, Studies Find

June 16, 2020

Cases of the most common type of liver cancer are expected to be increasingly associated with nonalcoholic steatohepatitits (NASH).

ICER Reports Play Significant Role in Managed Care’s Decision-Making, Study Finds

June 16, 2020

The Institute for Clinical and Economic Review appears to be an important source of information for managed care executives making decisions about treatment and cost.

Claim Analysis By Specialty Pharmacist Saves Health Plan $2.7 Million, Study Finds

May 20, 2020

A new study highlights the role a qualified specialty pharmacist can play in driving down costs across a health plan.

Adherence to Disease-Modifying Drugs Lowers Chronic Opioid Use in Patients with Inflammatory Conditions

May 19, 2020

A study of patients with inflammatory conditions who were prescribed biologic disease-modifying anti-rheumatic drugs had lower rates of chronic opioid use if they were adherent to their biologic therapy, according to new research.

Breakthrough Therapies, Opportunities for Savings in Near-term Specialty Pipeline

November 21, 2019

As more competition makes its way into the specialty drug market, there will be opportunities for cost savings.